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Gold nanoparticles have multiple applications including photoablation, diagnostic imaging, radiosensitization,
vaccine development, antioxidant, and multifunctional drug-delivery vehicles.
These applications require an increasingly complex level of surface decoration in order to achieve efﬁcacy, and
limit off-target toxicity. This review will discuss the chemical and physical approaches commonly utilized in re-
lation to surface decoration and the powerful system used to indicate success of the conjugation. Finally, we re-
view the range of recent studies about covalent and noncovalent modes for conjugation of antibodies to the
particle surface that aim to advance gold nanoparticle treatments and diagnostics toward the clinic.
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Nanotechnology suggests unique approaches to detect and regulate
diversity of biomedical processes that take place at nanometer scale,
and is expected to have a fundamental effect on biology and medicine.ter, Iran University of Medical
ri), pourfa@ibto.ir
edighimoghaddam).
. This is an open access article underNanoparticles the size of which falls into the range of biological mole-
cules and structures have attracted much attention in recent years for
their potential applications in biomedical research. Useful features can
be incorporated into nanoparticles for manipulation or detection of bio-
logical structures and events [1,2]. (See Tables A.1 and A.2.)
Different characteristics of nanoparticles such as size, shape and sur-
face charge have all been shown to strongly inﬂuence therapeutic and
diagnostic efﬁciency by changing cell uptake and functional surface
area. Nanoparticles are deﬁned as particles between 1 and 1000 nm
that have a range of unique properties including surface chemistry,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table A.1
Physical and chemical interactions between antibodies and gold nanoparticles surface in
bio conjugation process.
Physical interactions Chemical interactions
• Ionic interactions: between positively
charged groups in antibodies and the nega-
tively charged surface of the gold nanopar-
ticles
• Hydrophobic interactions: between hy-
drophobic parts of the antibody and the
gold nanoparticles surface
• Dative binding: between the gold
conducting electrons and amino acid sul-
fur atoms of the antibody
• Chemisorption via thiol deriva-
tives
• Bifunctional linkers or mediator
linkers: EDC/NHS chemistry
• Adapter molecules: like
Streptavidin andbiotin
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variety of applications containing drug and gen delivery [3], bioimaging
[4,5], vaccine development [6],biosensors, and therapies [7–11].
Bioconjugation simply involves the bond of biomolecules to nano-
particles by chemical or biological means, which render them ideal for
clinical applications; it includes the conjugation of biologically active
molecules to nanoparticles. The outcome is the combinations of beneﬁ-
cial properties [12].
The conjugation of different functionalized groups to nanoparticles
is necessary for their stability, functionality, and biocompatibility and
develops their application ﬁelds, and provides themwith novel and im-
proved properties [13]. A range of functionalized groupscan be attached
to the nanoparticles including low molecular weight ligands [14], pep-
tides [15,16], proteins [17], polysaccharides [18], polyunsaturated and
saturated fatty acids [19], DNA [20], plasmids, and siRNA [21–24].
2. Unique synthetic properties of gold nanoparticles (GNPs)
By using simple and biocompatible chemistry, it is possible to obtain
mono dispersed samples in the 5 nm to 50 nm size range [25]. This re-
view will describe the various interactions and modes used to
functionalize GNPs, and will provide a detailed overview of recent de-
velopments in bioconjugation.
2.1. Gold nanoparticles
Gold nanoparticles have been often studied due to their unique sur-
face, chemical inertness, high electron density, and strong optical ab-
sorption. In recent decades, gold nanoparticles have been applied in
genomics [3,26], clinical chemistry [27], vaccine development [28,29],
immunoassay [30], biosensors [31], diagnosis, and micro organisms
control [32], cancer-cell imaging, and drug delivery [33–35]. In addition,
it has been reported that GNPs conjugated by prostate speciﬁc mem-
brane antigen (PSMA) RNA aptamer after loading of doxorubicin can
be useful as therapeutic agents for diagnosis and treating of prostate
cancer [4]. It has also been reported that it is possible to control the in-
teractions of GNPs with cell membranes in order to improve their cellu-
lar uptake while minimizing their toxicity byrigid change of theirTable A.2
Non-covalent and covalent modes between antibodies and gold nanoparticles surface in
bioconjugation process.
Non-covalent modes Covalent modes
• Ionic interactions
• Hydrophobic
interactions
• Chemisorption via thiol derivatives
• Bifunctional linkers or mediator linkers:
EDC/NHS chemistry
• Adapter molecules: like Streptavidin andbiotin that
formed the complex
• Dative bindingsurface charges densities [36]. GNPs conjugated by PEG and
antibodyhave also been used as effective agents for plasmonic
photothermal therapy [37]. To develop observation of GNP based ther-
apeutics or diagnostic agents, the surface decoration is principally
esteemed necessary. Surface decoration or conjugation is commonly
used to improve drug loading, decrease immunogenicity, decrease ag-
gregation or increase stability, improve cellular uptake, actively target
cancer cells, and tumors. The ligand molecules bound to the nanoparti-
cles surface not only control the growth of the particles during synthe-
sis, but also prevent the aggregation of the nanoparticles. The repulsive
force between particles can, in principle, be due to electrostatic repul-
sion, steric exclusion, or a hydration layer on the surface [24].
The intricacy issues are associatedwith the conjunction of functional
groups to gold nanoparticle surface and conﬁrmation of bioconjugation.
2.2. Chemical synthesis of GNPs
A pointed understanding of the chemistry is needed to rightly syn-
thesize and functionalize GNPs, and develops successful nanoparticle
diagnostics and therapeutics. Gold nanoparticles have unique synthetic
properties [25].
The most routine protocol for GNP synthesis is the Turkevich meth-
od [38]. Brieﬂy, this method can be characterized as the reduction of
gold chloride with sodium citrate. The gold nanoparticles have an ab-
sorption maximum at 529 nm, and TEM shows an average size of gold
nanoparticles [38,39]. Other protocol for GNP synthesis is the Czech Pat-
ent Nomethod. Brieﬂy, chloroauric acid (HAuCl4) was heated to boiling
point. Then, aqueous solution of 1%trisodium citrate was added to the
HAuCl4 solution under rapid stirring and the GNPs were prepared by
crystallization. The citrate ions added as reducing agent for GNPs forma-
tion and asstabilizing agent, preventing aggregation or agglomeration of
GNPs [33]. The protocol for preparation of gold nanoparticles is wet
chemical methods which are based on the reduction of gold salts by re-
agents such as sodium borohydride and ascorbic acid [40]. Penades pre-
pared gold nanoparticles by reduction of Au(III) to Au(0) by NaBH4 in
the presence of a mixture of thiols [41].
The method reported by Wang and coworkersinvolves using atmo-
spheric-pressure non-thermal microplasma for the synthesis of gold
nanoparticles. Electrolyte solution consisting of Chloroauric acid
(HAuCl4) and sodium citrate (C6H5Na3O7·2H2O) in an electrochemical
cell at room temperature was exposed to the microplasma. Once the
microplasma was inﬂamed, the color of the HAuCl4 solution altered
gently from light yellow to pink, which displayed the formation of
GNPs [42].
2.3. Conjugation of GNPs
If the aim is to use gold nanoparticles in biomedicine as diagnostic
and therapeuticagents in cells or tissues, then, it is necessary to rightly
choose the targeting component such as a monoclonal antibody
(mAb), and the strategy to attach it on the surface of the particle [43].
GNPs conjugated byantibody orother functionalized groups have
also been used as effective agents for diagnostic and therapeutic appli-
cations [37]. Physical and chemical interactions are used for attaching
antibodies and other molecules to GNPs surface.
Physical Interaction between antibodies and gold nanoparticles de-
pends on three phenomena: (a) ionic attraction between the negatively
charged gold and the positively charged antibody; (b) hydrophobic at-
traction between the antibody and the gold surface; (c) dative binding
between the gold conducting electrons and amino acid sulfur atoms of
the antibody. Chemical interactions between antibodies and nanoparti-
cle surface are achieved in the number of ways like (i) chemisorption
via thiol derivatives; (ii) through the use of bifunctional linkers (iii),
and through the use of adapter molecules like Streptavidin andbiotin
[12,44].
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non-covalent immobilization modes have been used [45]. The antibod-
ies or other functionalized groups are nonspeciﬁcally adsorbed onto
gold nanoparticles while still keeping the nanoparticles negatively
charged, providing stability in colloidal solution [37]. In other words,
the bioconjugation protocol uses non-covalent modes of binding
based on a combination of electrostatic and hydrophobic interactions
of the antibody and the gold surface [40]. Non-covalent technique is de-
scribed as spontaneous absorption of antibodies onto the surface of cit-
rate stabilized nanoparticles; there are several types of interactions that
may occur in this process: hydrophobic interactions, ionic interactions
and etc. Hydrophobic interactions are due to attraction between hydro-
phobic parts of the antibody and themetal surface that result in the for-
mation of a non-covalent bond.Positively charged groups are abundant
in antibodies i.e., positively charged amino acids and the N-terminal are
present. Ionic interactions are formed between these groups and the
negatively charged surface of the particles [44].In recent years, Raja
Gopal Rayavarapu used this method to bind mouse monoclonal anti-
body speciﬁc to Human EGF Receptor 2 (HER2) to gold nanoparticles
whichwere then used as contrast agents for optical imaging techniques
ofbreast cancer [40]. Zhang and coworkers used non-covalent mode
forconjugation of 5-aminolevulinic acid to gold nanoparticleswhich
were then used for photodynamic therapy of cancer [46].
Sokolov used this method to bind anti-EGFR to gold nanospheres
whichwere described as new class of molecular speciﬁc contrast agents
for Real-Time Vital Optical Imaging of ovarian cancer cells based on gold
nanoparticles [47]. El-Sayed also used non-covalent modes to bind anti-
EGFR to gold nanoparticles inmolecular biosensor techniques for the di-
agnosis of oral cancer cells in vivo and in vitro [39].
In the work by Peng Chen and coworkers, the antibody adsorbed
onto the gold nanoparticles through a combination of ionic and hydro-
phobic interactionswhichwere then used as electrochemical label [48].
Hydrophobic and ionic interactions between antibody and gold
nanoparticle surface are illustrated in Fig. A.1.
Non-covalent modes have several major weaknesses; these include
the necessity of a high concentration of antibodies for the preparation
of antibody–gold particle conjugates, random orientation of antibodies
at the gold nanoparticle surface, and due to their electrostatic attraction
they are making the biological response difﬁcult to control; the binding
is impressed by changes in pH, and ultimately because antibodies areFig. A.1. Hydrophobic and ionic interactions between antibody and gold nanoparticle
surface. A) hydrophobic interaction B) ionic interaction C) a covalent bond is formed
due to dative binding [25].non-covalently conjugated to nanoparticles; they can be replaced by
other molecules in biological samples [45].
Covalent modes are also used to bind functionalized groups to gold
nanoparticle surface [45,49]. Gold nanoparticles can be used for direct
conjugationwith thiol group-containing bio-molecules such as antibod-
ies, and other biomolecules. Dative binding is a physical interaction that
may occur between antibody and GNPs surface. It is the formation of a
covalent bondbetween the gold nanoparticle and free sulfhydryl groups
of the antibody [44,51].
Covalent modes are also used to bind antibodies directly to the sur-
face of nanoparticles; These modes are used as a mediator linker, or can
take place via adaptermolecules like avidin and biotin for the formation
of the complex [45]. Functional groups present on the nanoparticle sur-
face can be converted to other functional groups by bifunctional mole-
cules. Particularly, in the case of nanoparticles dispersed in an aqueous
media, the reaction conditions may harm the stability of the nanoparti-
cles, so often rather mild reactions have to be selected like the ones ap-
plied for bioconjugation chemistry and a large number of bifunctional
molecules are commercially accessible. Usually found carboxylic groups
can be reacted with primary amines by means of a condensation reac-
tion to yield amide bonds. For this reason, a water-soluble carbodiimide
(e.g. EDC) is usually used. After forming an intermediate compound
with the carboxylic moiety, the activated group is reactive toward pri-
mary amines. In the case of primary amines present on the particle sur-
face, active ester compounds (N-hydroxy-succinimide; NHS) can be
used to equally form amide bonds [24].
Thiolated polyethylene glycol (PEG-SH) is used to coat bare gold
nanoparticles surfaces to decrease nonspeciﬁc interactions. The hydro-
philic nature of PEG also increases the biocompatibility of the conjugate.
The PEGylated gold nanoparticles used were carboxyl terminated,
providing a chemical group suitable for covalent binding. Although car-
boxyl groups do not spontaneously form bonds to antibodies, they can
be chemically modiﬁed to serve this purpose. The coupling chemistry
was EDC/NHS chemistry, which provides a covalent bond without the
addition of a spacer. Upon exposure of EDC/NHS to the carboxyl groups
reactive NHS esters are formed. When a primary amine group in an an-
tibody (or another protein) comes in contact with the ester, a covalent
bond is formed [52,53]. This reaction is illustrated in Fig. A.2.
The covalent binding of the thiol group to gold is used generally for
nanoparticle surface decoration. Liao used long chainsuccinimidyl 6-[3′-
[2-pyridyldithio]-propionamido] (LCSPDP) cross-linker hexanoate to
bind antibody to gold nanorods. The hetero bifunctional cross-linker
LC-SPDP was used to conjugate secondary antibodies to the nanorod
surface before PEGylation.LC-SPDP consists of a pyridildithio group
that binds to the gold nanorod surface, anda NHS ester which binds pri-
mary amines in the antibodies [54]. In the work by Loo and coworkers
the anti-HER2 antibodywas bound to a polyethylene glycol (PEG)linkerFig. A.2. An antibody is coupled to a PEGylated gold nanoparticle through EDC/NHS
chemistry. A reactive ester is created from a carboxyl group. Primary amines present in
an introduced antibody react and covalently bind to the ester, without addition of a
spacer [20].
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PEG-NHS), molecular weight of 2000] through a hydroxysuccinimide
group(NHS). The antibody–PEG linker complex was then attached to the
gold nanoshell surface through a sulfur containing group located at
the distal end of the PEG linker [55]. Shamsipur and coworkers used
this method to bind gold nanoparticles to multiwall carbon nanotube-
ionic liquid electrode, which were then used as a novel impedimetric
immunosensor for low level detection of human serum albumin in bio-
logical ﬂuids. For activation of colloidal gold nanoparticles (GNPs), GNPs
solution was added to N-hydroxy succinimide (NHS) containing N-
ethyl N-[3-dimethylaminopropyl] carbodiimide (EDC). The prepared
GNPs/HDT/GNP@MW-CILE electrode was ﬁnally immersed into the an-
tibody solution (Ab) to obtain Ab/GNP/HDT/GNP@MW-CILE electrode
[50]. Xia and coworker used succinimidyl propionyl polyethylene
glycoldisulﬁde (NHS-activated PEG) to conjugate antibodies to the sur-
face of a gold nanocage. NHS-activated PEGwas reactedwith the prima-
ry amine of antibody; then, the PEG-antibody complex was bonded to
the gold nanocage by breaking its internal disulﬁde bond and forming
an Au-S linkage as shown in Fig. A.3. [56].
1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide, EDC is using as a
mediator linker for conjugating antibody and other molecules to GNPs
via covalent bonds.
Conjugation is achieved by forming a peptide bond between N-ter-
minal primary amine of the protein and carboxylic acid groups of nega-
tively charged GNPs utilizing 1-Ethyl-3-[3-dimethylaminopropyl]
carbodiimide, EDC [57,58].
Damand coworkers used covalentmodes for attachment of oligonu-
cleotides with secondary structure on gold nanoparticles. Nucleic acids
thiolated to GNPs surface at pH = 1.7 because repulsion between the
negatively charged oligonucleotides and the GNPs surface decreases
[59]. Avidin–biotin complex also uses covalent modes to bind antibod-
ies to GNPs [45,60]. Biotin is a molecule attached to avidin/streptavidin
glycoproteins with high afﬁnity, selectivity and speciﬁcity that is an ex-
ample for the molecular key-and-lock system in biological processes as
shown in Fig. A.4. This method has a major shortcoming that with in-
creasing biotinylation nanoparticle surface becomesmore andmore hy-
drophobic and the biotinylated nanoparticles precipitate gradually in
aqueous solution [61–64].
Carbodiimide chemistry enables covalent immobilization of anti-
bodies to PEGylated gold nanoparticles. The covalent immobilization
assembles a stronger bond and a more stable conjugate than
physisorption [44].Fig. A.3. the NHS linker is used to conjugate antibodies to the surface of a gold nanocage
[56].2.4. Method and instruments for the conﬁrmation of bioconjugation GNPs
Sol particle immunoassay(SPIA) relies on two important properties
of gold sols: their characteristic bright red color, which remains approx-
imately unchangedon adsorption of high-molecularweight compounds
onto gold particles, and the noticeable change in the absorption spec-
trum, and thus in the sol color that attends particle aggregation; this
change in the absorption spectrum is easily detected spectrophotomet-
rically or visually. If the bio speciﬁc reaction continuation on the colloi-
dal particle surface results in sol destabilization, the gold particles
aggregatewhen polyclonal antibodies are used, and the process is called
agglutination leading tofundamental changes in the absorption spec-
trumwith a noticeable color change from red to blue or gray. It is possi-
ble to use the widely available spectrophotometers and colorimeters to
assess the reaction outcome [66]. Several techniques were used tomea-
sure the amount of bound conjugatethat is colorimetry and carbon rod
atomic absorption spectrophotometry (CRAAS) [67].
Longitudinal SPR is a tool for conﬁrmation of biomoleculars conjuga-
tion to gold nanoparticle surface.Lowvariations in the environment
around the GNRs can induce signiﬁcant changes in the longitudinal
SPR (LSPR) peak wavelength, which is much more sensitive than the
transverse SPR (TSPR) peak wavelength observed from gold nanoparti-
cles [68].
Leuvering used carbon rod atomic absorption
spectrophotometry(CRAAS) to measure the bound amount of silver
and goldconjugation [67].
Jans and coworkers usedDynamic Light Scattering as a powerful tool
for conﬁrmation of biomoleculars conjugation to gold nanoparticle sur-
face bymeasuring the average particle size change of the assay solution
[69].
Atomic forcemicroscopy is a powerful tool for the structural investi-
gation of biomolecular conjugation to GNPs surface and analysis of
bioconjugation-based nanostructures [70].
Zhang used UV–Visible (Vis) spectrophotometer to measure the ab-
sorbance spectrum of the ﬁnal solution and compare to the absorbance
spectrum of the primary solution to investigate for possible aggregation
of the solution [46]. Great changes in aggregationwill make a color shift
from red to blue or gray that is observable by eye [45]. The conjugation
of GNPs can beconﬁrmed by using a transmission electron microscopy,
and a particulate size description analyzer [46]. Confocal microscopy is
also used for conﬁrmation of bioconjugation [40]. The conjugation efﬁ-
ciency of the GNPs was conﬁrmed qualitatively and quantitatively
through gel electrophoresis, and critical ﬂocculation concentration anal-
ysis [71].3. Conclusion
Naturally, gold nanoparticles play a key role in future medicine by
providing unique properties like rich surface chemistry, low toxicity,
high electron density, and strong optical absorption. Understanding
the bioconjugation, chemistry of functionalization of GNPs and detec-
tion system of conjugation, opens novel opportunities for their use in
biomedicine. This review article mainly focuses on the chemical and
physical interactions of bioconjugation on the surface of gold nanopar-
ticles. These interactions discussed in this article formulate gold nano-
particles for various biological applications. The large surface to
volume ratio is the unique property, which is useful for the conjugation
of gold nanoparticles. Althoughmultifunctional gold nanoparticles con-
structed by the conjugation of various targeting molecules are exten-
sively investigated in the imaging and treatment of cancer cells and
tumors, controversial reports about toxicological issues of functional-
ized nanoparticles and shortcoming in conjugation limit the clinical ap-
plications of GNPs formulations. Therefore, a number of issues such as in
vivo and in vitro targeting efﬁciency, and toxicological issues of func-
tionalized gold nanoparticles are under rigorous investigation.
Fig. A.4. covalent modes of bioconjugation(a) a biotin–avidin is used to link the receptor and (b) carbodiimide chemistry is used for bioconjugation [65].
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